COMPACT SIZE
Small enough to fit in the palm of the hand
ON-BODY INJECTOR
The SKYRIZI “Instructions for Use” includes the full set of detailed instructions on the preparation and administration of SKYRIZI. Instruct the patient to read before administration.1
5 P’s to help your patients remember
ADMINISTRATION CONSIDERATIONS: SKYRIZI is intended for use under the guidance and supervision of a healthcare professional (HCP). Patients may self-inject SKYRIZI using the OBI with prefilled cartridge after training in subcutaneous injection technique. Provide proper training to patients and/or caregivers on the subcutaneous injetion technique of SKYRIZI according to the Instructions for Use.1
PATIENT-REPORTED EXPERIENCE ON USING THE OBI2,3
In a questionnaire, Crohn’s disease patients reported an experience with self-administration at home using the OBI after receiving training from their HCP2,3
DESCRIPTION: In an open-label, two-arm, multicenter study evaluating the SKRYIZI on-body injector (OBI) in adult patients with moderate-to-severe Crohn’s (N=46), analysis for patient experience was reported through questions within 6 domains of a validated Self-Injection Assessment Questionnaire (SIAQ). Data shown includes percent of patients that reported easy/very easy, very/extremely easy, or very/extremely confident for 3 questions within ease of use and satisfaction SIAQ domains at Week 8 (N=39). All data reported are observed. The SKYRIZI OBI was not evaluated in the primary analyses of the Phase 3 Clinical Trials in Crohn’s and UC.2,3
ADMINISTRATION CONSIDERATIONS: SKYRIZI is intended for use under the guidance and supervision of a healthcare professional (HCP). Patients may self-inject SKYRIZI using the OBI with prefilled cartridge after training in subcutaneous injection technique. Provide proper training to patients and/or caregivers on the subcutaneous injection technique of SKYRIZI according to the Instructions for Use.1
HCP=healthcare provider.
